Skip to content

Construction and application of breast reconstruction patient-spouse decision aid for breast cancer based on binary coping theory

Construction and application of breast reconstruction patient-spouse decision aid for breast cancer based on binary coping theory

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089051
Enrollment
Unknown
Registered
2024-08-30
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

treatment group:Routine medical decision care and preoperative health education are given, as well as adenocarcinoma breast reconstruction patient-spouse decision aid intervention. Then the doctor wil
Control group:Routine medical decision care and preoperative health education are given. Then the doctor will conduct the preoperative interview, fully communicate with the patient or family represent

Sponsors

Quanzhou First Hospital of Fujian Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patient inclusion criteria: ? Married patients with a living spouse; ? Meet the diagnostic criteria of breast cancer; ? Those who intend to do BR; ?Know your diagnosis and condition; ? Have complete language expression ability and understanding; ? Informed consent. 2. Spouse inclusion criteria: ? Spouse of the patient; Know the patient's disease diagnosis, condition and treatment; ? Have complete language expression ability and understanding; ? Informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for patients: ? have been enrolled in other investigators; ? mental anomaly; ? Patients with other malignant tumors; ? The body is too weak to complete the study. 2. Spouse exclusion criteria: ? has been included in other researchers; ? mental anomaly; ? Patients with other malignant tumors; ? The body is too weak to complete the study.

Design outcomes

Primary

MeasureTime frame
Decision conflict level;

Countries

China

Contacts

Public ContactLin Xiaolan

Quanzhou First Hospital of Fujian Province

15375880986@163.com+86 153 7588 0986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026